Erythropoietin and cisplatin neurotoxicity in cancer patients;Eritropoietina e neuropatie da cisplatino nei pazienti oncologici

Clinica Terapeutica

Volumn 153, Issue 3, 2002, Pages 177-180

  Mangiameli, A ^b   Spina, S ^a   Iannetti, E ^a   Catalano, D ^a   Spadaro, D ^a   Trovato, G M ^a,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b Casa di Cura Musumeci GECAS Srl   (Italy)

^c NONE   (Italy)

Author keywords

Cisplatin; Erythropoietin; Neurotoxicity; Oncology

Indexed keywords

CISPLATIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MUSCLE; NERVE; NEUROTOXICITY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; CISPLATIN; DATA INTERPRETATION, STATISTICAL; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; PLEURAL NEOPLASMS;

EID: 0036068046     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mechanisms of anaemia in patients with malignancy: Implications for the clinical use of recombinant human erythropoietin
2. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
3. Systolic function impairment in higher erythropoietin requirement dialysis patients
4. Quality of life in dialysis patients
5. Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain
6. Erythropoietin gene expression in human, monkey and murine brain
7. Localization of specific erythropoietin binding sites in defined areas of the mouse brain
8. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes
9. Regulated human erythropoietin receptor expression in mouse brain
10. In vivo evidence that erythropoietin protects neurons from ischemic damage
11. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
12. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes and muscle cramps
13. Autonomic dysfunction and anemia in neurologic disorders
14. Autonomic neuropathy in hemodialysis patients treated with recombinant human erythropoietin
15. Nonerythropoietic roles of erythropoietin in the fetus and neonate
16. Immunoistochemical localization of erythropoietin and its receptor in the developing human brain
17. Erythropoietin receptors are expressed in the central nervous system of midtrimester human fetus
18. Erythropoietin and erythropoietin receptor in the developing human central nervous system
19. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
20. Trophic effects of erytrhopoietin and other hematopoietic factors on central colinergic neurons in vitro and in vivo
21. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro
22. Identification of a neurotrophic sequence in erythropoietin
23. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential
24. New epoetin molecules and novel therapeutic approaches
25. Neuroprotective properties of epoetin alfa